Clear Labs, a genomics testing company based in the USA, specializes in providing comprehensive solutions for genetic analysis. Their cutting-edge, fully automated next-generation sequencing (NGS) platform offers a range of turnkey diagnostic services. These include the characterization and detection of SARS-CoV-2 genomic variants and the identification of foodborne pathogens such as listeria and salmonella. Additionally, Clear Labs can verify the ingredients of food products, determine their GMO status, and perform various tests.
The company contacted DICEUS to work on one of their products called Clear Dx™, particularly on SARS-CoV-2 Whole Genome Sequencing. The latter is an automated platform for genome sequencing of RNA extracts and assembling FASTA files for SARS-CoV-2 analysis.
Since the platform uses the Google Cloud Platform services, the company contacted DICEUS to create a new GCP environment, make the system more resilient, and improve data throughput to handle requests quickly.
Clear Labs, Inc. was established in 2014 by a team of software engineers and genomic scientists with a shared vision of introducing next-generation sequencing (NGS) technologies to food safety. The company’s mission is to support renowned food brands and service labs worldwide in guaranteeing the excellence and safety of their products.
It offers two solutions: clinical testing products and food safety testing products. Thus, Clear Lab’s state-of-the-art sequencing (NGS) platform can enhance efficiency and precision across various applications, from detecting food-borne pathogens to diagnosing infectious diseases. The platform revolutionizes sequencing technology, delivering faster results and improved accuracy for diverse genomic analyses.